Product Description
| Brand | Zybio |
| Sample Type | Plasma |
| Pack Size | 1 x 100T |
| CAT No | 01.09.49.07.01.02 |
Application | Tumor Marker |
ZYBIO CLIA Carcinoembryonic Antigen (CEA) reagent kit is designed for accurate quantitative determination of Carcinoembryonic Antigen (CEA) levels using chemiluminescent immunoassay technology. ZYBIO EXI CEA CLIA reagent is intended to aid in the monitoring of colorectal cancer, evaluation of treatment response, and detection of disease recurrence.Advanced Automatic OperationThe ZYBIO EXI CEA (CLIA) analyzer operates automatically, significantly minimizing manual intervention and improving workflow efficiency. Its real-time operation allows laboratory professionals to obtain rapid and accurate results for CEA determination, crucial in cancer diagnosis and monitoring patient progress.
Reliable CLIA TechnologyUtilizing Chemiluminescence Immunoassay (CLIA) technology, this equipment ensures sensitive and specific detection of Carcinoembryonic Antigen (CEA). The system's modern analytical methodology provides confidence in results, making it an excellent choice for healthcare facilities that require dependable laboratory solutions.
Portable and User-Friendly DesignDespite its advanced capabilities, the analyzer is compact and portable, enabling flexibility in laboratory space management. It is not wall-mounted, allowing it to be easily relocated as needed within different laboratory environments, greatly enhancing usability for Indian labs of varying sizes.
FAQ's of ZYBIO EXI CEA (CLIA):
Q: How does the ZYBIO EXI CEA (CLIA) analyzer function in the laboratory setting?
A: The analyzer operates automatically in real time using CLIA technology, enabling seamless and rapid determination of Carcinoembryonic Antigen (CEA) levels in patient samples. Its automation reduces manual workload and ensures consistent, reliable results.
Q: What makes Chemiluminescence Immunoassay (CLIA) technology advantageous for CEA detection?
A: CLIA technology is known for its high sensitivity and specificity, which allows the analyzer to deliver accurate and reproducible CEA results. This is particularly important in cancer diagnostics and monitoring, ensuring precise tracking of patient biomarkers.
Q: When should samples be stored, and what are the recommended storage conditions?
A: Samples and reagents intended for use with the ZYBIO EXI CEA (CLIA) analyzer should be stored at temperatures between 2 and 8C. Adhering to these storage parameters preserves sample integrity and ensures optimal assay performance.
Q: Where can the ZYBIO EXI CEA (CLIA) analyzer be deployed within a laboratory?
A: Its portable design allows placement on any stable laboratory bench, and it does not require wall mounting. This flexibility makes it suitable for various laboratory environments and allows for easy relocation when needed.
Q: What is the typical process for using this analyzer in CEA determination?
A: The user prepares the sample, loads it into the analyzer, and selects the relevant protocol. The automatic system then processes the sample and delivers quantitative results on CEA levels, all in real time with minimal manual intervention.
Q: How does real-time operation benefit laboratory workflows?
A: Real-time operation accelerates the analytical process, delivering rapid outcomes for patient care and reducing turnaround times. This efficiency allows laboratories to handle higher sample volumes without compromising accuracy.
Q: What are the main benefits of using the ZYBIO EXI CEA (CLIA) analyzer for laboratories in India?
A: Key benefits include automation, portability, reliable CLIA-based results, easy integration into laboratory workflows, and low maintenance requirements. The device supports diverse laboratory needs, enhancing both productivity and diagnostic quality.